Opinion
Video
Author(s):
Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.
Childhood Cancer Survivors May Experience Sooner Aging-Related Disease
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Longer Imbruvica and Venclexta Treatment May Be Beneficial in R/R CLL
The Treatment Journey of a Patient with CLL
Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL